Optometrists in Ashland, WI Accepting Medicare

4 Optometrists found. Showing 1 - 4

Camile D Sateren, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 1615 Maple Lane, Ashland, WI 54806 Phone: 715-685-5513    Fax: 715-682-4022

Jake Pray, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2111 Beaser Ave, Ashland, WI 54806 Phone: 715-682-0363    Fax: 715-682-9638

Corwin James Sateren, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 218 Main St W, Ashland, WI 54806 Phone: 715-682-4666    Fax: 715-682-4984

Sateren Eye Care, S.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 218 Main St W, Ashland, WI 54806 Phone: 715-682-4666    Fax: 715-682-4984

News Archive

Study confirms accuracy of developmental screening tests for children

BC Children's Hospital and University of British Columbia (UBC) researchers have found that two existing screening tests are accurate in diagnosing development delays in children and could be incorporated in a busy family practice setting with relative ease.

Researchers report three-fold increase in use of minimally invasive surgery for pancreatic disease

Researchers at University of California, San Diego School of Medicine report a three-fold increase in the use of minimally invasive surgery across the nation for patients with pancreatic disease. Although adaptation of MIS for this difficult-to-reach gland is recent, the growing trend points to improved patient outcomes, such as reduced bleeding and infections. Now published online, the paper will appear in the March print edition of JAMA Surgery.

Dehaier Medical fourth quarter revenues increase 126% to $6.7 million

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial results for the fourth quarter and 12 months ended December 31, 2010.

Is the confidence in hydroxychloroquine for the management of COVID-19 justified?

A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.

Read more Medical News

› Verified 8 days ago